IMARC Group, a leading market research company, has recently releases report titled “Single Use Bioreactor Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global single use bioreactor market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big is the Single Use Bioreactor Market?
The global single-use bioreactors market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2028, exhibiting a growth rate (CAGR) of 15.3% during 2023-2028.
What is Single Use Bioreactor?
A single-use bioreactor is used in the biopharmaceutical industry for the cultivation of cells and microorganisms. It is made of disposable plastic bags and chambers, which do not require sterilization between batches and offer various advantages, including reduced risk of contamination, increased flexibility, and shorter turnaround times. It also eliminates the need for cleaning and validation and can be easily scaled up or down depending on the needs of the process. At present, single-use bioreactor finds application in pharmaceutical and biopharmaceutical companies, contract research organizations, and academic and research institutes across the globe.
Request Free Sample Copy of This Report: https://www.imarcgroup.com/single-use-bioreactor-market/requestsample
What are the growth prospects and trends in the single use bioreactor industry?
Presently, the burgeoning healthcare sector and increasing adoption of single-use bioreactors in academic and commercial-scale laboratories for drug discovery, biofuel manufacturing, and development of vaccines and antibodies represent one of the key factors positively influencing the market. In addition, single-use bioreactors are more environment friendly than traditional bioreactors as they use less resources and generate minimum waste.
Moreover, they require less energy to operate and transport, which is creating a favorable market outlook. Apart from this, the growing awareness about the benefits of single-use bioreactors and increasing focus on sustainability are driving the market.
Furthermore, the development of new materials and sensor technologies are contributing to improving the performance and reliability of single-use bioreactors, which is stimulating the growth of the market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product Type:
- Single-use Bioreactor Systems
- Media Bags
- Filtration Assemblies
- Others
Breakup by Type:
- Stirred-tank Bioreactors
- Wave-induced Bioreactors
- Bubble-column Bioreactors
- Others
Breakup by Cell Type:
- Mammalian Cell
- Bacteria
- Yeast
- Others
Breakup by Molecule Type:
- Vaccines
- Monoclonal Antibodies
- Stem Cells
- Recombinant Proteins
- Others
Breakup by End User:
- Pharmaceutical and Biopharmaceutical Companies
- Contract Research Organizations
- Academic and Research Institutes
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- ABEC Inc.
- Cellexus
- Celltainer Biotech B.V.
- CESCO Bioengineering Co. Ltd.
- Distek Inc.
- Eppendorf SE
- General Electric Company
- Getinge AB
- Merck KGaA
- Pall Corporation (Danaher Corporation)
- PBS Biotech Inc.
- Sartorius AG
- Thermo Fisher Scientific Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
About Author
